Atara Biotherapeutics Insider Trades
NASDAQ: ATRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $5.74M
- Sales
- 14 · $3.83M
- Shares bought / sold
- 611.57K / 417.91K
- Net activity
- Net buying $1.9 million
Atara Biotherapeutics insider activity
Over the last 12 months, Atara Biotherapeutics insiders reported 28 transactions on SEC Form 4: 2 open-market purchases and 14 sales. Insiders bought $5.7 million and sold $3.8 million worth of stock, for net insider buying of $1.9 million. The largest seller was Panacea Innovation Ltd & Huang James, with $3.7 million in reported sales.
The most recent filing shows Nguyen AnhCo (President and CEO) selling 6,094 shares at $6.46 on Nov 16, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ATRA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ATRA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 16, 2026 | Nguyen AnhCoPresident and CEO | Sale | 6,094 | $39.37K | Form 4 |
| Sep 4, 2026 | Cherry Brian NDirector | Buy | 104,166 | $999.99K | Form 4 |
| Aug 17, 2026 | Nguyen AnhCoPresident and CEO | Sale | 5,062 | $40.88K | Form 4 |
| Jul 22, 2026 | Redmile Group, LLC & Green JeremyDirector | Tax withholding | 60 | — | Form 4 |
| Jul 22, 2026 | Redmile Group, LLC & Green JeremyDirector | Option exercise | 195,211 | — | Form 4 |
| Jun 11, 2026 | Cherry Brian NDirector | Award | 24,000 | — | Form 4 |
| Jun 9, 2026 | Fust Matthew KDirector | Award | 12,000 | — | Form 4 |
| Jun 9, 2026 | HEIDEN WILLIAM KDirector | Award | 12,000 | — | Form 4 |
| Jun 9, 2026 | Ciongoli Gregory AustinDirector | Award | 12,000 | — | Form 4 |
| May 18, 2026 | Grant-Huerta YaninaChief Accounting Officer | Sale | 2,414 | $22.04K | Form 4 |
| May 18, 2026 | Nguyen AnhCoPresident and CEO | Sale | 5,241 | $47.84K | Form 4 |
| May 7, 2026 | EcoR1 Capital, LLC10% Owner | Buy | 507,407 | $4.74M | Form 4 |
| May 7, 2026 | Panacea Innovation Ltd & Huang James10% Owner | Sale | 313,446 | $3.17M | Form 4 |
| Mar 17, 2026 | Panacea Innovation Ltd & Huang James10% Owner | Tax withholding | 5 | $26.15 | Form 4 |
| Mar 17, 2026 | Panacea Innovation Ltd & Huang James10% Owner | Option exercise | 259,163 | $25.92 | Form 4 |
| Mar 9, 2026 | Grant-Huerta YaninaChief Accounting Officer | Award | 20,300 | — | Form 4 |
| Mar 9, 2026 | Nguyen AnhCoPresident and CEO | Award | 81,100 | — | Form 4 |
| Mar 2, 2026 | Nguyen AnhCoPresident and CEO | Sale | 1,442 | $7.34K | Form 4 |
| Mar 2, 2026 | Nguyen AnhCoPresident and CEO | Sale | 1,298 | $6.60K | Form 4 |
| Mar 2, 2026 | Nguyen AnhCoPresident and CEO | Sale | 58 | $294.64 | Form 4 |
| Mar 2, 2026 | Nguyen AnhCoPresident and CEO | Sale | 198 | $1.01K | Form 4 |
| Mar 2, 2026 | Grant-Huerta YaninaChief Accounting Officer | Sale | 100 | $508.30 | Form 4 |
| Mar 2, 2026 | Grant-Huerta YaninaChief Accounting Officer | Sale | 377 | $1.92K | Form 4 |
| Mar 2, 2026 | Grant-Huerta YaninaChief Accounting Officer | Sale | 1,603 | $8.14K | Form 4 |
| Mar 2, 2026 | Grant-Huerta YaninaChief Accounting Officer | Sale | 24 | $121.85 | Form 4 |
| Jan 12, 2026 | Panacea Innovation Ltd & Huang James10% Owner | Sale | 80,554 | $489.02K | Form 4 |
| Nov 28, 2025 | Panacea Innovation Ltd & Huang James10% Owner | Tax withholding | 1 | $14.03 | Form 4 |
| Nov 28, 2025 | Panacea Innovation Ltd & Huang James10% Owner | Option exercise | 48,737 | $4.87 | Form 4 |
| Nov 17, 2025 | Nguyen AnhCoPresident and CEO | Sale | 56 | $738.53 | Form 4 |
| Nov 17, 2025 | Nguyen AnhCoPresident and CEO | Sale | 2,859 | $37.70K | Form 4 |
| Nov 17, 2025 | Grant-Huerta YaninaChief Accounting Officer | Sale | 74 | $976.13 | Form 4 |
| Nov 17, 2025 | Grant-Huerta YaninaChief Accounting Officer | Sale | 85 | $1.12K | Form 4 |
| Nov 17, 2025 | Grant-Huerta YaninaChief Accounting Officer | Sale | 1,645 | $21.69K | Form 4 |
| Aug 18, 2025 | Grant-Huerta YaninaChief Accounting Officer | Sale | 1,668 | $19.37K | Form 4 |
| Aug 18, 2025 | Grant-Huerta YaninaChief Accounting Officer | Sale | 86 | $998.72 | Form 4 |
| Aug 18, 2025 | Grant-Huerta YaninaChief Accounting Officer | Sale | 55 | $638.50 | Form 4 |
| Aug 18, 2025 | Nguyen AnhCoPresident and CEO | Sale | 1,620 | $18.82K | Form 4 |
| Aug 18, 2025 | Nguyen AnhCoPresident and CEO | Sale | 1,281 | $14.88K | Form 4 |
| Aug 18, 2025 | Nguyen AnhCoPresident and CEO | Sale | 57 | $661.94 | Form 4 |
| Aug 15, 2025 | Panacea Innovation Ltd & Huang James10% Owner | Buy | 55,000 | $670.42K | Form 4 |
| Jul 17, 2025 | Panacea Innovation Ltd & Huang James10% Owner | Buy | 19,335 | $186.37K | Form 4 |
| Jun 10, 2025 | HEIDEN WILLIAM KDirector | Award | 7,828 | — | Form 4 |
| Jun 10, 2025 | Roncarolo Maria GraziaDirector | Award | 7,828 | — | Form 4 |
| Jun 10, 2025 | Fust Matthew KDirector | Award | 7,828 | — | Form 4 |
| Jun 10, 2025 | Gallagher Carol GiltnerDirector | Award | 7,828 | — | Form 4 |
| Jun 10, 2025 | MALLIK AMEETDirector | Award | 7,828 | — | Form 4 |
| Jun 10, 2025 | Touchon PascalDirector | Award | 7,828 | — | Form 4 |
| May 16, 2025 | Adiumentum Capital Fund I LP & Adiumentum Capital Fund I GP LLC & Ciongoli Gregory AustinDirector | Award | 75,572 | $499.53K | Form 4 |
| May 16, 2025 | Nguyen AnhCoPresident and CEO | Sale | 3,276 | $22.16K | Form 4 |
| May 16, 2025 | Grant-Huerta YaninaChief Accounting Officer | Sale | 2,218 | $15.00K | Form 4 |
| Mar 3, 2025 | Henrich JillEVP, Chief Regulatory Officer | Sale | 1,059 | $7.41K | Form 4 |
| Mar 3, 2025 | Hyllengren Eric JEVP, CFO and COO | Sale | 1,211 | $8.47K | Form 4 |
| Mar 3, 2025 | Nguyen AnhCoPresident and CEO | Sale | 3,331 | $23.31K | Form 4 |
| Jan 27, 2025 | Hyllengren Eric JEVP, CFO and COO | Award | 34,050 | — | Form 4 |
| Nov 18, 2024 | Hyllengren Eric JEVP, CFO and COO | Sale | 1,364 | $15.27K | Form 4 |
| Nov 18, 2024 | Henrich JillEVP, Chief Regulatory Officer | Sale | 1,000 | $11.20K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4